Gene therapy for colorectal cancer

Daniel Palmer, Ming-Jen Chen, David Kerr

Research output: Contribution to journalArticle

15 Citations (Scopus)


Gene therapy has been developed as a potential novel treatment modality for colorectal cancer. The preclinical data have been promising and several clinical trials are under way for colorectal cancer. Data from many phase 1 trials have proven the safety of the reagents, but have not yet demonstrated significant therapeutic benefit. In order to refine this approach, continuing efforts should be made to improve the antitumour potency, efficiency of gene delivery, and accuracy of gene targeting. It is likely that gene therapy will be integrated into pre-existing therapies including surgery, chemotherapy and radiotherapy to establish its niche in tomorrow's medicine.
Original languageEnglish
Pages (from-to)201-225
Number of pages25
JournalBritish Medical Bulletin
Publication statusPublished - 1 Dec 2002


Dive into the research topics of 'Gene therapy for colorectal cancer'. Together they form a unique fingerprint.

Cite this